A Phase II Clinical Study of AK104/AK112 in Combination With TT-00420 Tablet for Advanced HCC.

A Study of AK112 in Patients With Advanced Hepatocellular Carcinoma (HCC)

NCT06530251 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

A Study of Anti-PD-1/CTLA-4 Bispecific AK104 Alone or in Combination With Lenvatinib in Advanced Hepatocellular Carcinoma

NCT04728321 ·Status: COMPLETED ·Phase: PHASE2

A Study of Anti-PD-1/CTLA-4 Bispecific AK104 Plus Lenvatinib in First-line Advanced Hepatocellular Carcinoma

NCT04444167 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Study to Evaluate the Efficacy and Safety of TT-00420 (Tinengotinib) in Cholangiocarcinoma

NCT04919642 ·Status: COMPLETED ·Phase: PHASE2

A Study of Second-line Treatment With Apatinib for Advanced Intrahepatic Cholangiocarcinoma

NCT03521219 ·Status: UNKNOWN ·Phase: PHASE2

AK104 Combining With TACE for Resectable Hepatocellular Carcinoma (MORNING)

NCT05578430 ·Status: UNKNOWN ·Phase: PHASE2

Efficacy and Safety of TT-00420 (Tinengotinib) Tablets Versus Chemotherapy in Patients With Advanced Intrahepatic Cholangiocarcinoma Harboring FGFR2 Fusions/Rearrangements or Mutations

NCT07328919 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3

TQB2450 Combined With Anlotinib Hydrochloride in the Perioperative Treatment of Hepatocellular Carcinoma Hydrochloride Neoadjuvant Therapy for Resectable Hepatocellular Carcinoma With a High Risk of Recurrence or Metastasis

NCT04888546 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

A Study of AK104+Lenvatinib in Combination With Transarterial Chemoembolization (TACE) Versus TACE in Participants With Incurable/Non-metastatic Hepatocellular Carcinoma

NCT06371157 ·Status: RECRUITING ·Phase: PHASE3

Nocardia Rubra Cell Wall Skeleton (N-CWS) Plus HAIC, Lenvatinib and Tislelizumab in Treating Patients With Advanced HCC

NCT05533892 ·Status: RECRUITING ·Phase: PHASE1

Anlotinib for Hepatocellular Carcinoma

NCT04954521 ·Status: UNKNOWN

SHR-1210 Combined With Apatinib Mesylate in the Perioperative Treatment of Hepatocellular Carcinoma

NCT04297202 ·Status: UNKNOWN ·Phase: PHASE2

Sorafenib With Capecitabine and Oxaliplatin for Advanced or Metastatic Hepatocellular Carcinoma

NCT00752063 ·Status: UNKNOWN ·Phase: PHASE2

Combined Immunotherapy and Targeted Therapy for Hepatocellular Carcinoma

NCT04152356 ·Status: UNKNOWN

The Efficacy of Sequential RT After Triple Therapy for uHCC

NCT07052448 ·Status: ENROLLING_BY_INVITATION

QL1706 As Second-line Treatment in Patients with Advanced Hepatocellular Carcinoma

NCT06822985 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1

Combine Apatinib Mesylate With PD-1 Antibody SHR-1210 for HCC With High Risk of Recurrence After Radical Resection

NCT03839550 ·Status: UNKNOWN ·Phase: PHASE2

Lenvatinib Combined With Gefitinib in the Treatment of Lenvatinib-resistant Hepatocellular Carcinoma

NCT04642547 ·Status: COMPLETED ·Phase: NA

Study of Anlotinib After Lenvatinib in Patients With Hepatocellular Carcinoma

NCT04080154 ·Status: UNKNOWN ·Phase: PHASE2

The Comparison of TACE-Lenvatinib With TACE-Lenvatinib-ablation for Intermediate Recurrent Hepatocellular Carcinoma

NCT06609850 ·Status: RECRUITING ·Phase: NA

A Study of AK130 in Combination With AK112 for the Treatment of Advanced Biliary Tract Cancer

NCT06938321 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

TACE/HAIC Combined With Lenvatinib and Sintilimab in Neoadjuvant Therapy for Intermediate-stage HCC

NCT05250843 ·Status: RECRUITING ·Phase: PHASE2/PHASE3

KN046 Combined With Ningatinib in the Treatment of Advanced Hepatocellular Carcinoma

NCT04601610 ·Status: TERMINATED ·Phase: PHASE1/PHASE2

Adjuvant Chemotherapy Based on the Adenosine Triphosphate Tumor Chemosensitivity Assay for Hepatocellular Carcinoma After Liver Transplantation

NCT02580253 ·Status: WITHDRAWN ·Phase: PHASE2

A Study of TAE+HAIC Combined With Camrelizumab and Apatinib in the Treatment of Advanced Hepatocellular Carcinoma

NCT06363825 ·Status: RECRUITING ·Phase: PHASE2